Legis Daily

Safe and Affordable Drugs from Canada Act of 2019

USA116th CongressHR-478| House 
| Updated: 1/25/2019
Chellie Pingree

Chellie Pingree

Democratic Representative

Maine

Cosponsors (15)
Tim Ryan (Democratic)John Garamendi (Democratic)Jared F. Golden (Democratic)Ed Case (Democratic)Thomas P. Tiffany (Republican)Max Rose (Democratic)Steve Cohen (Democratic)Angie Craig (Democratic)Ro Khanna (Democratic)David P. Joyce (Republican)Daniel Lipinski (Democratic)Peter Welch (Democratic)Elissa Slotkin (Democratic)Jaime Herrera Beutler (Republican)Lloyd Doggett (Democratic)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Safe and Affordable Drugs from Canada Act of 2019 This bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy if the drug is dispensed by a pharmacist licensed in Canada; is purchased for personal use in quantities not greater than a 90-day supply; is filled using a valid prescription issued by a physician licensed to practice in the United States; and has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved by the FDA. Under the bill, certain drugs may not be imported, including controlled substances and biological products. The bill establishes a certification process for approving Canadian pharmacies. The FDA must publish a list of approved Canadian pharmacies.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 9, 2019

Latest Companion Bill Action

S 116-61
Introduced in Senate
Jan 10, 2019
Introduced in House
Jan 10, 2019
Referred to the House Committee on Energy and Commerce.
Jan 25, 2019
Referred to the Subcommittee on Health.
  • January 9, 2019

    Latest Companion Bill Action

    S 116-61
    Introduced in Senate


  • January 10, 2019
    Introduced in House


  • January 10, 2019
    Referred to the House Committee on Energy and Commerce.


  • January 25, 2019
    Referred to the Subcommittee on Health.

Health

Related Bills

  • S 116-3384: Lowering Prescription Drug Prices for America’s Seniors and Families Act of 2020
  • S 116-61: Safe and Affordable Drugs from Canada Act of 2019
Administrative law and regulatory proceduresCanadaDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationGovernment information and archivesPrescription drugsTrade restrictions

Safe and Affordable Drugs from Canada Act of 2019

USA116th CongressHR-478| House 
| Updated: 1/25/2019
Safe and Affordable Drugs from Canada Act of 2019 This bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy if the drug is dispensed by a pharmacist licensed in Canada; is purchased for personal use in quantities not greater than a 90-day supply; is filled using a valid prescription issued by a physician licensed to practice in the United States; and has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved by the FDA. Under the bill, certain drugs may not be imported, including controlled substances and biological products. The bill establishes a certification process for approving Canadian pharmacies. The FDA must publish a list of approved Canadian pharmacies.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 9, 2019

Latest Companion Bill Action

S 116-61
Introduced in Senate
Jan 10, 2019
Introduced in House
Jan 10, 2019
Referred to the House Committee on Energy and Commerce.
Jan 25, 2019
Referred to the Subcommittee on Health.
  • January 9, 2019

    Latest Companion Bill Action

    S 116-61
    Introduced in Senate


  • January 10, 2019
    Introduced in House


  • January 10, 2019
    Referred to the House Committee on Energy and Commerce.


  • January 25, 2019
    Referred to the Subcommittee on Health.
Chellie Pingree

Chellie Pingree

Democratic Representative

Maine

Cosponsors (15)
Tim Ryan (Democratic)John Garamendi (Democratic)Jared F. Golden (Democratic)Ed Case (Democratic)Thomas P. Tiffany (Republican)Max Rose (Democratic)Steve Cohen (Democratic)Angie Craig (Democratic)Ro Khanna (Democratic)David P. Joyce (Republican)Daniel Lipinski (Democratic)Peter Welch (Democratic)Elissa Slotkin (Democratic)Jaime Herrera Beutler (Republican)Lloyd Doggett (Democratic)

Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 116-3384: Lowering Prescription Drug Prices for America’s Seniors and Families Act of 2020
  • S 116-61: Safe and Affordable Drugs from Canada Act of 2019
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresCanadaDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationGovernment information and archivesPrescription drugsTrade restrictions